Table 2.
Comparison of clinical data in spondylarthritis patients with and without uveitis of the Included studies.
| Study | BASDAI | BASFI | ASDAS-CRP | CRP | ESR | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Uveitis | Uveitis | Uveitis | Uveitis | Uveitis | ||||||
| + yes | − no | + | − | + | − | + | − | + | − | |
| Chen 200717 | 4.9 (2.4) | 3.9 (2.0) | 4.2 (2.9) | 2.8 (2.4) | ||||||
| Wendling 20126 | 4.3 (2.1) | 4.5 (2.0) | 2.6 (2.2) | 3.1 (2.3) | 2.6 (1.0) | 2.5 (1.0) | 9.2 (12.2) | 9.0 (14.6) | 11.8 (13.0) | 14.0 (15.1) |
| Gehlen 201218 | 4.4 (2.4) | 3.3 (2.5) | 3.4 (3.3) | 4.7 (3.0) | ||||||
| Sampaio-Barros 201319 | 4.3 (2.4) | 4.3 (4.5) | 4.5 (2.9) | 4.2 (2.9) | 11.4 (18.3)) | 8.0 (14.5) | 25.3 (21.2) | 24.0 (19.8)) | ||
| Berg 20147 | 4.0 (2.0) | 3.5 (1.7) | 2.7 (2.2) | 1.7 (1.7) | 2.4 (1.0) | 2.2 (0.9) | 5.0 (5.2) | 5.0 (7.4) | 17.0 (14.8) | 17.0 (16.3) |
| Diss 201420 | 5.9 (0.4) | 5.8 (0.3) | 4.5 (0.6) | 4.5 (0.4) | ||||||
| Costa 201521 | 4.2 (2.5) | 4.2 (2.6) | ||||||||
| Lian 201510 | 6.6 (2.8) | 5.9 (3.1) | 5.7 (2.6) | 6.5 (3.7) | 2.4 (0.6) | 2.2 (0.5) | 38.4 (17.9) | 40.3 (19.3) | 78.6 (24.5) | 92.3 (33.1) |
| 2.5 (0.7)* | 2.8 (0.9)* | |||||||||
| Essers 201514 | 3.4 (2) | 3.5 (2.2) | 3.3 (2.3) | 3.4 (2.7) | 2.7 (0.8) | 2.7 (1.1) | 15.4 (15.1) | 18.6 (26.2) | 11.7 (7.9) | 15.3 (17.0) |
| Przepiera-Bedzak 20168 | 5.8 (2.8) | 3.9 (2.7) | 2.8 (0.9)* | 2.4 (0.9)* | 11.4 (13.7) | 6.1 (7.0) | 18.0 (22.2) | 14.7 (13.7) | ||
| Kasifoglu 201822 | 5.6 (2.2) | 5.7 (2.1) | 3.6 (2.4) | 4.3 (2.7) | 17.9 (20.7) | 14.8 (17.0) | 29 (27.4) | 24.7 (21.5) | ||
| Bilge 201923 | 5.3 (2.3) | 5.6 (2.1) | 3.6 (2.4) | 4.3 (2.7) | 17.5 (21.4) | 14.7 (17.0) | 27.7 (26.0) | 23.3 (20.7) | ||
| Redeker 202015 | 4.4 (0.1) | 4.5 (0.1) | 4.2 (0.1) | 4.0 (0.1) | ||||||
| Man 20219 | 2.2 (1.0) | 2.0 (1.0) | ||||||||
Values are shown as mean (SD).
BASDAI Bath Ankylosing Spondylitis Disease Activity Index, BASFI Bath Ankylosing Spondylitis Functional Index, ASDAS Ankylosing Spondylitis Disease Activity Score, CRP C-reactive protein, ESR erythrocyte sedimentation rate.
*ASDAS-ESR.